What is the appropriate ciprofloxacin (Cipro) dose for a child weighing 32.3 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ciprofloxacin Dosing for 32.3 kg Child

For a child weighing 32.3 kg, administer ciprofloxacin 10-15 mg/kg every 12 hours, which translates to 323-485 mg every 12 hours, not exceeding 1000 mg total daily dose. 1

Specific Dosing Calculations

For this 32.3 kg child:

  • Standard dose: 10 mg/kg every 12 hours = 323 mg every 12 hours (646 mg/day)
  • Upper range: 15 mg/kg every 12 hours = 485 mg every 12 hours (970 mg/day)
  • Maximum daily limit: 1000 mg/day regardless of weight-based calculation 1

Route-Specific Recommendations

Intravenous Administration

  • 10 mg/kg every 8-12 hours IV (maximum 400 mg/dose) 2
  • For this child: 323 mg every 12 hours IV
  • Alternative for severe infections: Can dose every 8 hours if needed 3

Oral Administration

  • 15 mg/kg every 8-12 hours PO (maximum 500 mg every 8 hours or 750 mg every 12 hours) 2
  • For this child: 485 mg every 12 hours PO
  • The 1000 mg daily maximum still applies 1

Indication-Specific Considerations

For dysentery/typhoid: 15 mg/kg twice daily for 3-7 days 4

For anthrax exposure: 10-15 mg/kg every 12 hours for 60 days (not exceeding 1 g/day) 1

For Haemophilus influenzae pneumonia: 30 mg/kg/day IV divided every 12 hours as alternative therapy 3

Critical Dosing Caveats

  • The 1000 mg daily maximum is absolute - even if weight-based calculations suggest higher doses, do not exceed this limit in children 1
  • For this 32.3 kg child, the weight-based calculation (485 mg BID = 970 mg/day) stays within the 1000 mg daily cap
  • Ciprofloxacin is generally not first-line in children due to concerns about cartilage toxicity; reserve for serious infections where benefits outweigh risks 5
  • Recent pharmacokinetic data suggests standard pediatric dosing may be suboptimal in critically ill children with normal/elevated renal function, potentially requiring 15 mg/kg every 8 hours 6, 7, but this remains off-label

Practical Administration

  • Oral bioavailability is approximately 60% 8, 9
  • If switching from IV to PO, increase dose by approximately 50% to maintain similar exposure
  • Avoid co-administration with dairy products, antacids, or enteral feeding (separate by 2 hours before and after) 10
  • Monitor for tendinitis, QTc prolongation, and dysglycemia 11

References

Research

Developing tailored dosing recommendations for ciprofloxacin in critically ill children using a population approach based on total and unbound concentrations.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2025

Research

Population pharmacokinetics of ciprofloxacin in pediatric patients.

Journal of clinical pharmacology, 2003

Research

Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients.

Antimicrobial agents and chemotherapy, 1996

Research

Administration of ciprofloxacin through a nasogastric tube in pediatric oncology and stem cell transplantation patients.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023

Research

Drug Utilization Evaluation Study of Ciprofloxacin Use and Adverse Events Occurrence: Role of Community Pharmacists.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.